Palladia® (Toceranib Phosphate) - Targeted Anti-Cancer Therapy for Dogs & Cats
- In stock, ready to ship
- Worldwide Shipping
- Fast Delivery (In 8-15 Days)
- 14-Days Money Back
- Secure Checkout
Pairs well with
Targeted Anti-Cancer Therapy for Dogs and Cats
A cancer diagnosis in your pet is one of the most difficult moments a pet owner can face. Palladia® (Toceranib Phosphate) is an FDA-approved targeted tyrosine kinase inhibitor (TKI) that attacks cancer at the molecular level — blocking tumor growth signals and cutting off the blood supply tumors need to grow, while minimizing damage to healthy tissue.
How Palladia® Works
Palladia selectively inhibits tyrosine kinase receptors — proteins that cancer cells rely on to receive growth signals and stimulate new blood vessel formation (angiogenesis). By blocking these pathways, Palladia:
- Inhibits tumor cell proliferation and survival signaling
- Disrupts tumor angiogenesis — cutting off the blood supply that feeds tumor growth
- Targets cancer at the molecular level rather than broadly attacking all dividing cells
Clinical Applications
- Dogs — Mast Cell Tumors (FDA-approved) — the primary approved indication for recurrent or non-resectable cutaneous mast cell tumors in dogs
- Cats — Off-label oncology use — increasingly used by veterinary oncologists for various feline neoplastic and proliferative diseases under specialist guidance
Why Choose Palladia®?
- FDA-approved targeted therapy — the first receptor tyrosine kinase inhibitor approved for veterinary oncology
- Oral administration — convenient tablet form avoids the need for frequent clinic visits for IV chemotherapy
- Targeted mechanism — selectively attacks tumor signaling pathways, reducing collateral damage to healthy tissue
- Proven clinical efficacy — widely used in veterinary oncology clinics worldwide
Available Strengths
- 10 mg × 30 tablets
- 15 mg × 30 tablets
- 50 mg × 30 tablets
Recommended Use
Palladia® is a prescription veterinary oncology medication that must be prescribed and monitored by a veterinarian or veterinary oncologist. Regular blood work and clinical monitoring are essential during treatment. Handle tablets with care — use gloves and avoid crushing or splitting tablets.